Results 11 to 20 of about 34,423 (243)

Comparative Study of Elevated CA19-9 Levels in Non-Gastrointestinal Tumors Patients: Evaluation of Different Immunoassay Methods and Analysis of Potential Interfering Factors [PDF]

Biomedicines
Objectives: CA19-9 elevation in non-gastrointestinal tumor patients may be influenced by various non-tumor factors, which poses challenges for clinical diagnosis.
Yangyang Liu, Wenxuan Li, Shaoxi Tang, Ruihao Wu, Yumin Wang, Fanggui Shao   +5 more
doaj   +2 more sources

MUC1 and glycan probing of CA19-9 captured biomarkers from cyst fluids and serum provides enhanced recognition of ovarian cancer [PDF]

Scientific Reports
Glycosylation changes of circulating proteins carrying the CA19-9 antigen may offer new targets for detection methods to be explored for the diagnosis of epithelial ovarian cancer (EOC). Search for assay designs for targets initially captured by a CA19-9
Shamima Afrin Ruma, Rufus Vinod, Shruti Jain, Kaisa Huhtinen, Johanna Hynninen, Janne Leivo, Kim Pettersson, Karin Sundfeldt, Kamlesh Gidwani   +8 more
doaj   +2 more sources

Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophore. [PDF]

, 2014
The aim of this study is to determine the efficacy of neoadjuvant chemotherapy (NAC) with gemcitabine (GEM) in combination with fluorescence-guided surgery (FGS) on a pancreatic cancer patient derived orthotopic xenograft (PDOX) model.
Bouvet, Michael, Chishima, Takashi, Endo, Itaru, Fleming, Jason B, Hiroshima, Yukihiko, Hoffman, Robert M, Ichikawa, Yasushi, Katz, Matthew HG, Maawy, Ali, Matsuyama, Ryusei, Momiyama, Masashi, Mori, Ryutaro, Murakami, Takashi, Tanaka, Kuniya, Zhang, Yong   +14 more
core   +11 more sources

Importance of Normalization of Carbohydrate Antigen 19-9 in Patients With Intrahepatic Cholangiocarcinoma

Frontiers in Oncology, 2021
BackgroundAlthough carbohydrate antigen 19-9 (CA19-9) is an established prognostic marker for intrahepatic cholangiocarcinoma (ICC) patients, the significance of elevated preoperative CA19-9 that normalized after resection remains unknown.
Hui Li, Hui Li, Yuan Feng, Yuan Feng, Chang Liu, Jiawang Li, Jiaxin Li, Hong Wu, Genshu Wang, Dewei Li   +9 more
doaj   +1 more source

Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas

BMC Cancer, 2021
Background CA19–9 is one of the most widely used tumor markers in biliary-pancreatic diseases. The measured value may not factually reflect the genuine CA19–9 level secreted by tumor, which affected by biliary obstruction.
Bangbo Zhao, Qin Cheng, Hongtao Cao, Xingtong Zhou, Tianhao Li, Liangbo Dong, Weibin Wang   +6 more
doaj   +1 more source

Abdominal Pain and Increased CA19-9 [PDF]

Clinical Chemistry, 2013
A 32-year-old man with an unremarkable medical history presented to the ambulatory clinic with complaints of nonlocalized abdominal pain. The results of a physical examination were unremarkable. The results obtained from liver, pancreatic, and renal testing were within the reference intervals, and the results of both a fecal occult blood test and an ...
Graziani G., Cucchiari D., Podesta' M. A., Quagliuolo V., Montanelli A.   +4 more
openaire   +2 more sources

Elevated tumor markers in a benign lung disease

Journal of Cardiothoracic Surgery, 2021
Background This study aimed to determine the underlying pathophysiologic mechanism of elevated carbohydrate antigen 19-9 (CA19-9) in pulmonary sequestration (PS) patients. Materials and methods Four pulmonary sequestration patients, 12 pneumonia patients
Quan Chen, Qijue Lu, Xiang Fei, Chunguang Li, Bai Li   +4 more
doaj   +1 more source

Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer patients: 5-year-follow-up of a single center

Frontiers in Oncology, 2022
BackgroundPancreatic cancer mortality is growing every year, and radical resection is the most essential therapy strategy. It is critical to evaluate the long-term prognosis of individuals receiving radical surgery.
Zuowei Wu, Pengcheng Zhao, Zihe Wang, Xing Huang, Chao Wu, Mao Li, Li Wang, Bole Tian   +7 more
doaj   +1 more source

Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9

Frontiers in Oncology, 2020
Recently we showed that delta radiomics features (DRF) from daily CT-guided chemoradiation therapy (CRT) is associated with early prediction of treatment response for pancreatic cancer.
Haidy Nasief, William Hall, Cheng Zheng, Susan Tsai, Liang Wang, Beth Erickson, X. Allen Li   +6 more
doaj   +1 more source

Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access (R) GI Monitor assay on the UniCel (R) Dxl 800 Immunoassay System [PDF]

, 2008
Background: Gastrointestinal cancer antigen CA19-9 is known as a valuable marker for the management of patients with pancreatic cancer. Methods: The analytical and clinical performance of the Access(R) GI Monitor assay (Beckman Coulter) was evaluated on ...
Barone D, Bekaii-Saab TS, Dittadi R, Gogas H, Heinemann V, Ishii H, Jiang XT, Magnani JL, Micke O, Molina R, Reiter W, Reiter W, Safi F, Steinberg W, Tempero MA, Wang WS   +15 more
core   +3 more sources